Public Health Scotland has published data from the Scottish Renal Registry (SRR) pertaining to patients with end-stage renal disease (ESRD) receiving renal replacement therapy (RRT) who have tested positive for COVID-19. The SSR is a national registry of all Scottish patients receiving RRT, including haemodialysis, peritoneal dialysis and transplants.
Patients receiving dialysis or kidney transplant recipients are considered a vulnerable population. Patients undergoing dialysis typically tend to be older and have other comorbidities. Such patients often need to visit a health care facility on a regular basis, which further heightens their risk of exposure to SARS-CoV-2.
Key findings from the report as of 31 May 2020 are as follows:
- Between 1 March 2020 and 31 May 2020, 110 patients receiving RRT in Scotland tested positive for COVID-19. This figure corresponds to 2 per cent of the total RRT population in Scotland.
- Positive COVID-19 tests among patients receiving RRT peaked between the week beginning 30 March 2020 and 6 April 2020.
- Patients undergoing haemodialysis, individuals aged 44-74 years and those residing in more socially deprived areas accounted for the highest number of positive COVID-19 tests
- As of 31 May 2020, 28.2 per cent of patients on RRT who tested positive for COVID-19 had died.
- The survival rate at 30 days following the first positive COVID-19 test was estimated to be 78 per cent.